Kindred Biosciences Inc
KIN
Get informed when a big investor buys or sells
+ FollowMarket Cap$0
Close$
$9.55
3.2% upside
Current Fair Value
3.2% upsideUndervalued by 3.2% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $0.00 |
|---|---|
| Enterprise Value | $-23,489,000.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.6 |
| Beta | 1.32 |
| Outstanding Shares | 45,277,000 |
Return
| Return on Equity | -54.69% |
|---|---|
| Return on Assets | -40.07% |
| Return on Invested Capital | -41.26% |
Valuation & Multiples
| P/E Ratio | -15.38 |
|---|---|
| PEG | 10.96 |
| Price to Sales | - |
| Price to Book Ratio | 9.25 |
| Enterprise Value to Revenue | -2.96 |
| Enterprise Value to EBIT | 0.58 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.99 |
| Debt to Equity | 0.29 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Kindred Biosciences Inc
140 employees
CEO: Richard Chin Kindred Biosciences is a biopharmaceutical company developing innovative biologics focused on saving and improving the lives of pets. Its mission is to bring to pets the same kinds of safe and effective medicines that human family member...